The Scoop: Biodata Comes “Ome” to Roost
Genomic, Transcriptomic, and Metabolomic Data Can’t Be Free, But It Can Be “Free Range”
Playing Catch-Up with Optogenetic Effects
Optogenetically Triggered Processes Needn’t Become Visualization and Mapping Blurs
New Paradigms to Maximize Partnering Value in Biotech
Some Key Considerations for Life Sciences Companies Evaluating Collaboration Agreements
Celebrating 65 Years of DNA Discoveries
Check out GEN's Video in Honor of National DNA Day
For full access to this article login to GEN Select now.
Biotech Embroiders Intricate Glycopatterns
Glycans Account for Some of the More Ornate Weavings from Nature's Post-Translational Loom
- Through its association with monoclonal antibody quality, safety, and efficacy, glycosylation remains a hot issue for biotech. Accordingly, improving glycosylation is a priority for companies such as Agilent Technologies, which has undertaken several initiatives to improve glycan analysis within the context of the company’s analytical systems. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.